FDA approves new injection to treat hives
Note: this article is provided by ONU Healthwise Pharmacy.
There's a newly approved treatment for hives.
The US Food and Drug Administration (FDA) has approved Quzyttir (cetirizine) to treat acute urticaria (hives).
Available as an injection to be given into the vein (IV), this new medication is approved for adults and children 6 months of age and older.
Cetirizine injection is now an alternative treatment option to IV diphenhydramine (brand name Benadryl).
The approved dose is once every 24 hours as needed for acute hives.
This approval comes after cetirizine injection was shown to be effective in a clinical trial that included 262 adults with hives. Some patients received cetirizine injection, while others received diphenhydramine injection.
Common side effects may include headache, altered taste, feeling hot, indigestion and excessive sweating. This medication may cause drowsiness. Be cautious if driving or operating heavy machinery.
Speak with your health care provider if you have any questions about hives or the available treatments.
Stories Posted This Week
Saturday, October 31, 2026
Friday, October 30, 2026
Thursday, October 29, 2026
- Bluffton Icon headlines, October 29
- Kenton missing person investigation leads to arrests and discovery of deceased individual
- Ada Council meeting rescheduled for November 10
- District Governor urges Ada Rotary to make lasting impact
- Apollo Career Center honored as Gold Star Institution
- Leading fish expert to deliver Keiser Lecture at Ohio Northern on Nov. 3
- Down Memory Lane: ONU Homecoming celebration in 1925
- Test-to-Treat not Trick-or-Treat
Wednesday, October 28, 2026
Tuesday, October 27, 2026
- Bulldogs Allen, Rush voted 1st team by NCOSA coaches
- Ada girls soccer eliminated by Grove in district semis
- Northwest Ohio field reports from the Ohio Division of Wildlife
- Can you look up Rotarian in the dictionary?
- Vancrest of Ada to host purse bingo in Kenton
- Karen Kier named to Soroptimist International Gender Medicine Working Group
- Ada ballot for Nov. 3 includes ambulance district, public library and two park district tax levy issues
